Results 31 to 40 of about 76,888 (317)
Novel psychoactive substances: the pharmacology of stimulants and hallucinogens [PDF]
Expert Review of Clinical Pharmacology, 2016 There are increasing levels of concern relating to the rapidly evolving novel psychoactive substances/NPS and web markets' scenarios. The paper aims at providing an overview of the clinical pharmacological issues related to some of the most popular NPS categories, e.g. stimulants and hallucinogens.
John Martin Corkery +2 more
exaly +3 more sources
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
Medicina, 2021 Background and Objectives: Over the past twenty years a large number of new psychoactive substances (NPS) have entered and modified the recreational drug scene.
Stefania Chiappini +10 more
doaj +3 more sources
Detecting novel psychoactive substances around the world
Current Opinion in PsychiatryPurpose of review The worldwide spread of novel psychoactive substances (NPS) in the illicit drug market and their continuous increase in number and type, for the purpose of bypassing controlled substance legislation, represents a continuing challenge ...
A. Salomone, Marco Vincenti
semanticscholar +4 more sources
Novel psychoactive substance [PDF]
Clinical Medicine, 2021 Editor – We read with interest the article entitled ‘Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital’ by Tanti et al .[1][1] The team have effectively highlighted the high rates of psychiatric comorbidity, unemployment,
Mark, Pucci +2 more
openaire +2 more sources
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Brain Sciences, 2021 Introduction: Cognitive enhancers (CEs), also known as “smart drugs”, “study aids” or “nootropics” are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university students.
Safia Sharif +3 more
doaj +1 more source
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2017 There has been a significant increase in the number of new intoxicants on the illegal drugs market globally, also in Norway. The substances are given the name NPS: Novel Psychoactive Substances, and are mainly sold over the Internet. Uncertain dosage of potent substances entails a risk of accidental overdose, and therefore serious intoxication and ...
M.T. Zanda, L. Fattore
+6 more sources
Brain Sciences, 2023 The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes.
Davide Arillotta +7 more
doaj +1 more source
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Frontiers in Psychiatry, 2021 COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of
Valeria Catalani +8 more
doaj +1 more source
Screening Unknown Novel Psychoactive Substances Using GC-MS Based Machine Learning [PDF]
, 2022 In recent years, there is a large increase in structural diversity of novel psychoactive substances (NPS), exacerbating drug abuse issues as these variants evade classical detection methods such as spectral library matching.
Swee Liang, Wong +3 more
core +1 more source
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
Brain Sciences, 2021 The restrictive measures adopted during the COVID-19 pandemic modified some previously consolidated drug use patterns. A focus on social networks allowed drug users to discuss, share opinions and provide advice during a worldwide emergency context.
Davide Arillotta +4 more
doaj +1 more source